In this articlePFEFollow your favorite stocksCREATE FREE ACCOUNT The ongoing Covid-19 pandemic propelled pharmaceutical company Pfizer's earnings to a record $100 billion last year, almost $57 billion of which was driven by its vaccine and antiviral pill Paxlovid, the company reported Tuesday. The vaccine accounted for $37.8 billion, up just 3% from 2021, of Pfizer's